| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | AMPA glutamate receptor activity | 4.29e-07 | 4 | 96 | 3 | GO:0004971 | |
| GeneOntologyMolecularFunction | glutamate-gated receptor activity | 6.97e-05 | 17 | 96 | 3 | GO:0004970 | |
| GeneOntologyMolecularFunction | histone H3K4 methyltransferase activity | 1.16e-04 | 20 | 96 | 3 | GO:0042800 | |
| GeneOntologyMolecularFunction | triplex DNA binding | 1.36e-04 | 4 | 96 | 2 | GO:0045142 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 1.63e-04 | 57 | 96 | 4 | GO:1904315 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 1.99e-04 | 60 | 96 | 4 | GO:0099529 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 2.03e-04 | 24 | 96 | 3 | GO:0099507 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 2.71e-04 | 65 | 96 | 4 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 2.71e-04 | 65 | 96 | 4 | GO:0022824 | |
| GeneOntologyMolecularFunction | glutamate receptor activity | 2.90e-04 | 27 | 96 | 3 | GO:0008066 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 4.70e-04 | 75 | 96 | 4 | GO:0098960 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 5.19e-04 | 77 | 96 | 4 | GO:0005230 | |
| GeneOntologyMolecularFunction | glutamate-gated calcium ion channel activity | 6.29e-04 | 8 | 96 | 2 | GO:0022849 | |
| GeneOntologyMolecularFunction | beta-2 adrenergic receptor binding | 1.00e-03 | 10 | 96 | 2 | GO:0031698 | |
| GeneOntologyMolecularFunction | histone H3K4 trimethyltransferase activity | 1.00e-03 | 10 | 96 | 2 | GO:0140999 | |
| GeneOntologyMolecularFunction | 5'-3' DNA helicase activity | 1.22e-03 | 11 | 96 | 2 | GO:0043139 | |
| GeneOntologyMolecularFunction | DNA endonuclease activity | 1.24e-03 | 44 | 96 | 3 | GO:0004520 | |
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 1.24e-03 | 44 | 96 | 3 | GO:0140938 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 1.38e-03 | 100 | 96 | 4 | GO:0030594 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 1.67e-03 | 262 | 96 | 6 | GO:0140097 | |
| GeneOntologyMolecularFunction | histone H3K36 methyltransferase activity | 1.72e-03 | 13 | 96 | 2 | GO:0046975 | |
| GeneOntologyMolecularFunction | G-quadruplex DNA binding | 2.00e-03 | 14 | 96 | 2 | GO:0051880 | |
| GeneOntologyMolecularFunction | nuclear retinoic acid receptor binding | 2.36e-03 | 55 | 96 | 3 | GO:0042974 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 2.41e-03 | 193 | 96 | 5 | GO:0015276 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 2.53e-03 | 118 | 96 | 4 | GO:0003774 | |
| GeneOntologyMolecularFunction | adenylate cyclase binding | 2.63e-03 | 16 | 96 | 2 | GO:0008179 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 2.63e-03 | 197 | 96 | 5 | GO:0022834 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 2.79e-03 | 614 | 96 | 9 | GO:0140657 | |
| GeneOntologyMolecularFunction | DNA helicase activity | 3.32e-03 | 62 | 96 | 3 | GO:0003678 | |
| GeneOntologyMolecularFunction | DNA replication origin binding | 3.33e-03 | 18 | 96 | 2 | GO:0003688 | |
| GeneOntologyMolecularFunction | SUMO ligase activity | 4.11e-03 | 20 | 96 | 2 | GO:0061665 | |
| GeneOntologyMolecularFunction | DNA nuclease activity | 4.13e-03 | 67 | 96 | 3 | GO:0004536 | |
| GeneOntologyMolecularFunction | phosphatidylinositol binding | 4.22e-03 | 316 | 96 | 6 | GO:0035091 | |
| GeneOntologyMolecularFunction | protein-lysine N-methyltransferase activity | 4.31e-03 | 68 | 96 | 3 | GO:0016279 | |
| GeneOntologyMolecularFunction | lysine N-methyltransferase activity | 4.49e-03 | 69 | 96 | 3 | GO:0016278 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 4.67e-03 | 140 | 96 | 4 | GO:0099094 | |
| GeneOntologyMolecularFunction | histone methyltransferase activity | 4.86e-03 | 71 | 96 | 3 | GO:0042054 | |
| GeneOntologyBiologicalProcess | vesicle cargo loading | 7.71e-07 | 36 | 99 | 5 | GO:0035459 | |
| GeneOntologyBiologicalProcess | female gamete generation | 1.01e-04 | 223 | 99 | 7 | GO:0007292 | |
| GeneOntologyBiologicalProcess | oogenesis | 1.07e-04 | 156 | 99 | 6 | GO:0048477 | |
| GeneOntologyBiologicalProcess | oocyte development | 1.15e-04 | 99 | 99 | 5 | GO:0048599 | |
| GeneOntologyBiologicalProcess | endoplasmic reticulum to Golgi vesicle-mediated transport | 1.18e-04 | 159 | 99 | 6 | GO:0006888 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription elongation by RNA polymerase II | 1.31e-04 | 54 | 99 | 4 | GO:0032968 | |
| GeneOntologyBiologicalProcess | oocyte differentiation | 1.39e-04 | 103 | 99 | 5 | GO:0009994 | |
| GeneOntologyBiologicalProcess | positive regulation of T-helper 17 type immune response | 1.77e-04 | 23 | 99 | 3 | GO:2000318 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA-templated transcription, elongation | 2.25e-04 | 62 | 99 | 4 | GO:0032786 | |
| GeneOntologyCellularComponent | endoplasmic reticulum exit site | 1.51e-06 | 42 | 98 | 5 | GO:0070971 | |
| GeneOntologyCellularComponent | presynaptic active zone membrane | 3.29e-05 | 78 | 98 | 5 | GO:0048787 | |
| GeneOntologyCellularComponent | presynaptic active zone | 5.35e-05 | 141 | 98 | 6 | GO:0048786 | |
| GeneOntologyCellularComponent | neurotransmitter receptor complex | 8.86e-05 | 50 | 98 | 4 | GO:0098878 | |
| GeneOntologyCellularComponent | core mediator complex | 2.40e-04 | 26 | 98 | 3 | GO:0070847 | |
| GeneOntologyCellularComponent | AMPA glutamate receptor complex | 3.70e-04 | 30 | 98 | 3 | GO:0032281 | |
| GeneOntologyCellularComponent | midbody | 6.26e-04 | 222 | 98 | 6 | GO:0030496 | |
| GeneOntologyCellularComponent | mediator complex | 6.92e-04 | 37 | 98 | 3 | GO:0016592 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 7.85e-04 | 523 | 98 | 9 | GO:0098984 | |
| GeneOntologyCellularComponent | postsynaptic density membrane | 8.68e-04 | 157 | 98 | 5 | GO:0098839 | |
| GeneOntologyCellularComponent | Ctf18 RFC-like complex | 9.55e-04 | 10 | 98 | 2 | GO:0031390 | |
| GeneOntologyCellularComponent | centrosome | DDX12P FBXL13 OFD1 HAP1 HAUS3 LATS1 ASPM CFAP58 CEP152 CDC25B DDX11L8 | 9.59e-04 | 770 | 98 | 11 | GO:0005813 |
| GeneOntologyCellularComponent | dendritic spine | 9.80e-04 | 242 | 98 | 6 | GO:0043197 | |
| GeneOntologyCellularComponent | neuron spine | 1.09e-03 | 247 | 98 | 6 | GO:0044309 | |
| GeneOntologyCellularComponent | microtubule organizing center | DDX12P FBXL13 OFD1 HAP1 HAUS3 NLRP3 LATS1 ASPM CFAP58 CEP152 CDC25B DDX11L8 | 1.22e-03 | 919 | 98 | 12 | GO:0005815 |
| GeneOntologyCellularComponent | ionotropic glutamate receptor complex | 1.23e-03 | 45 | 98 | 3 | GO:0008328 | |
| GeneOntologyCellularComponent | postsynaptic density | 1.28e-03 | 451 | 98 | 8 | GO:0014069 | |
| GeneOntologyCellularComponent | glutamatergic synapse | PRUNE2 GPM6A AKAP5 MYO6 GRIA1 GRIA3 GRIA4 CNKSR2 PDE10A RYK NR3C2 | 1.54e-03 | 817 | 98 | 11 | GO:0098978 |
| GeneOntologyCellularComponent | postsynaptic density, intracellular component | 1.57e-03 | 49 | 98 | 3 | GO:0099092 | |
| GeneOntologyCellularComponent | excitatory synapse | 1.62e-03 | 107 | 98 | 4 | GO:0060076 | |
| GeneOntologyCellularComponent | asymmetric synapse | 1.82e-03 | 477 | 98 | 8 | GO:0032279 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | DDX12P MIS18BP1 KMT2B MED9 IVNS1ABP LIG3 SNRNP48 PBRM1 R3HCC1L BRD4 MED11 MED25 FIP1L1 AFF1 DDX11L8 | 1.83e-03 | 1377 | 98 | 15 | GO:0140513 |
| GeneOntologyCellularComponent | actin-based cell projection | 1.99e-03 | 278 | 98 | 6 | GO:0098858 | |
| GeneOntologyCellularComponent | postsynaptic specialization, intracellular component | 2.31e-03 | 56 | 98 | 3 | GO:0099091 | |
| GeneOntologyCellularComponent | postsynaptic specialization | 2.52e-03 | 503 | 98 | 8 | GO:0099572 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 2.58e-03 | 201 | 98 | 5 | GO:0099634 | |
| GeneOntologyCellularComponent | filopodium | 2.69e-03 | 123 | 98 | 4 | GO:0030175 | |
| GeneOntologyCellularComponent | spindle pole | 2.81e-03 | 205 | 98 | 5 | GO:0000922 | |
| GeneOntologyCellularComponent | presynapse | PRUNE2 GPM6A MYO6 HAP1 ATCAY SYT9 GRIA1 GRIA3 GRIA4 RYK NR3C2 | 2.90e-03 | 886 | 98 | 11 | GO:0098793 |
| GeneOntologyCellularComponent | dendritic spine membrane | 3.17e-03 | 18 | 98 | 2 | GO:0032591 | |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | 4.02e-03 | 223 | 98 | 5 | GO:0098862 | |
| GeneOntologyCellularComponent | dendritic shaft | 5.09e-03 | 74 | 98 | 3 | GO:0043198 | |
| Domain | ASH | 2.30e-05 | 2 | 90 | 2 | IPR031549 | |
| Domain | ASH | 2.30e-05 | 2 | 90 | 2 | PF15780 | |
| Domain | Iontro_rcpt | 8.38e-05 | 18 | 90 | 3 | IPR001320 | |
| Domain | Lig_chan-Glu_bd | 8.38e-05 | 18 | 90 | 3 | PF10613 | |
| Domain | Iono_rcpt_met | 8.38e-05 | 18 | 90 | 3 | IPR001508 | |
| Domain | Glu/Gly-bd | 8.38e-05 | 18 | 90 | 3 | IPR019594 | |
| Domain | Lig_chan-Glu_bd | 8.38e-05 | 18 | 90 | 3 | SM00918 | |
| Domain | Lig_chan | 8.38e-05 | 18 | 90 | 3 | PF00060 | |
| Domain | PBPe | 8.38e-05 | 18 | 90 | 3 | SM00079 | |
| Domain | BNIP2 | 1.37e-04 | 4 | 90 | 2 | PF12496 | |
| Domain | Bcl2-/adenovirus-E1B | 1.37e-04 | 4 | 90 | 2 | IPR022181 | |
| Domain | IQ | 3.83e-04 | 71 | 90 | 4 | PF00612 | |
| Domain | IQ | 6.32e-04 | 81 | 90 | 4 | SM00015 | |
| Domain | ANF_lig-bd_rcpt | 7.47e-04 | 37 | 90 | 3 | IPR001828 | |
| Domain | BROMODOMAIN_1 | 7.47e-04 | 37 | 90 | 3 | PS00633 | |
| Domain | ANF_receptor | 7.47e-04 | 37 | 90 | 3 | PF01094 | |
| Domain | P-loop_NTPase | GTPBP4 MYO1D CENPE MYO6 ZRANB3 NLRP3 DNAH1 SAMD9L N4BP2 ASPM HYDIN ARL14 | 7.48e-04 | 848 | 90 | 12 | IPR027417 |
| Domain | Bromodomain | 8.08e-04 | 38 | 90 | 3 | PF00439 | |
| Domain | Peripla_BP_I | 8.72e-04 | 39 | 90 | 3 | IPR028082 | |
| Domain | IQ_motif_EF-hand-BS | 9.39e-04 | 90 | 90 | 4 | IPR000048 | |
| Domain | SET | 1.01e-03 | 41 | 90 | 3 | PF00856 | |
| Domain | BROMODOMAIN_2 | 1.01e-03 | 41 | 90 | 3 | PS50014 | |
| Domain | IQ | 1.06e-03 | 93 | 90 | 4 | PS50096 | |
| Domain | BROMO | 1.08e-03 | 42 | 90 | 3 | SM00297 | |
| Domain | Bromodomain | 1.08e-03 | 42 | 90 | 3 | IPR001487 | |
| Domain | - | 1.08e-03 | 42 | 90 | 3 | 1.20.920.10 | |
| Domain | BAH | 1.23e-03 | 11 | 90 | 2 | SM00439 | |
| Domain | BAH | 1.23e-03 | 11 | 90 | 2 | PF01426 | |
| Domain | BAH | 1.23e-03 | 11 | 90 | 2 | PS51038 | |
| Domain | BAH_dom | 1.23e-03 | 11 | 90 | 2 | IPR001025 | |
| Domain | SET | 1.41e-03 | 46 | 90 | 3 | SM00317 | |
| Domain | CRAL_TRIO_2 | 1.47e-03 | 12 | 90 | 2 | PF13716 | |
| Domain | SET_dom | 1.80e-03 | 50 | 90 | 3 | IPR001214 | |
| Domain | SET | 1.80e-03 | 50 | 90 | 3 | PS50280 | |
| Domain | Post-SET_dom | 2.64e-03 | 16 | 90 | 2 | IPR003616 | |
| Domain | PostSET | 2.64e-03 | 16 | 90 | 2 | SM00508 | |
| Domain | POST_SET | 2.64e-03 | 16 | 90 | 2 | PS50868 | |
| Domain | CRAL_TRIO | 4.54e-03 | 21 | 90 | 2 | PF00650 | |
| Pathway | REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS | 2.44e-07 | 29 | 68 | 5 | MM15028 | |
| Pathway | REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS | 3.47e-07 | 31 | 68 | 5 | M7223 | |
| Pathway | REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS | 5.75e-05 | 16 | 68 | 3 | MM15048 | |
| Pathway | REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS | 6.96e-05 | 17 | 68 | 3 | M5488 | |
| Pathway | WP_NRXN1_DELETION_SYNDROME | 8.32e-05 | 18 | 68 | 3 | M48098 | |
| Pathway | REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES | 1.15e-04 | 20 | 68 | 3 | MM15485 | |
| Pathway | REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES | 1.34e-04 | 21 | 68 | 3 | M27736 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 1.34e-04 | 21 | 68 | 3 | M838 | |
| Pathway | WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA | 1.55e-04 | 22 | 68 | 3 | M39795 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 1.55e-04 | 22 | 68 | 3 | MM15104 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 4.55e-04 | 205 | 68 | 6 | M752 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 6.29e-04 | 35 | 68 | 3 | MM15109 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 6.45e-04 | 144 | 68 | 5 | MM14501 | |
| Pathway | REACTOME_CARGO_CONCENTRATION_IN_THE_ER | 6.84e-04 | 36 | 68 | 3 | MM15300 | |
| Pathway | REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES | 8.16e-04 | 87 | 68 | 4 | M27617 | |
| Pathway | WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION | 1.00e-03 | 41 | 68 | 3 | M39655 | |
| Pubmed | AKAP5 MYO1D ZNF658 U2SURP ASH1L GRIA1 FAM47B GRIA3 GRIA4 CTAGE6 PDE10A MIPOL1 SNRNP48 LATS1 N4BP2 CTAGE8 MED11 SCN9A ASPM CTAGE15 CTAGE4 | 8.74e-10 | 1442 | 101 | 21 | 35575683 | |
| Pubmed | Motor protein-dependent transport of AMPA receptors into spines during long-term potentiation. | 1.55e-09 | 18 | 101 | 5 | 18311135 | |
| Pubmed | 2.38e-08 | 3 | 101 | 3 | 12172541 | ||
| Pubmed | 2.38e-08 | 3 | 101 | 3 | 19217372 | ||
| Pubmed | 9.49e-08 | 4 | 101 | 3 | 10688364 | ||
| Pubmed | AMPA receptor subunits expressed by single astrocytes in the juvenile mouse hippocampus. | 9.49e-08 | 4 | 101 | 3 | 9221927 | |
| Pubmed | Interaction proteomics reveals brain region-specific AMPA receptor complexes. | 9.49e-08 | 4 | 101 | 3 | 25337787 | |
| Pubmed | Auditory sensitivity regulation via rapid changes in expression of surface AMPA receptors. | 9.49e-08 | 4 | 101 | 3 | 17828255 | |
| Pubmed | 9.49e-08 | 4 | 101 | 3 | 24652293 | ||
| Pubmed | 9.49e-08 | 4 | 101 | 3 | 17409242 | ||
| Pubmed | 9.49e-08 | 4 | 101 | 3 | 14561864 | ||
| Pubmed | 9.49e-08 | 4 | 101 | 3 | 1319477 | ||
| Pubmed | AMPA receptors regulate dynamic equilibrium of presynaptic terminals in mature hippocampal networks. | 9.49e-08 | 4 | 101 | 3 | 12692557 | |
| Pubmed | 9.49e-08 | 4 | 101 | 3 | 12125045 | ||
| Pubmed | 9.49e-08 | 4 | 101 | 3 | 9648857 | ||
| Pubmed | 2.37e-07 | 5 | 101 | 3 | 16129400 | ||
| Pubmed | 2.37e-07 | 5 | 101 | 3 | 9482932 | ||
| Pubmed | 8.25e-07 | 7 | 101 | 3 | 21368048 | ||
| Pubmed | Hippocampal AMPA receptor assemblies and mechanism of allosteric inhibition. | 8.25e-07 | 7 | 101 | 3 | 33981040 | |
| Pubmed | Impairment of AMPA receptor function in cerebellar granule cells of ataxic mutant mouse stargazer. | 8.25e-07 | 7 | 101 | 3 | 10407040 | |
| Pubmed | Glutamate receptors in cortical plasticity: molecular and cellular biology. | 8.25e-07 | 7 | 101 | 3 | 9016303 | |
| Pubmed | Glutamate receptors: brain function and signal transduction. | 8.25e-07 | 7 | 101 | 3 | 9651535 | |
| Pubmed | 8.25e-07 | 7 | 101 | 3 | 27076426 | ||
| Pubmed | Hippocampal AMPA receptor gating controlled by both TARP and cornichon proteins. | 1.32e-06 | 8 | 101 | 3 | 21172611 | |
| Pubmed | Synaptic profiles during neurite extension, refinement and retraction in the developing cochlea. | 1.32e-06 | 8 | 101 | 3 | 23217150 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | PRUNE2 TIGAR UACA MYO6 ASH1L TMEM63C STK32C PDE10A NSMCE2 SEC22A ATP10A DNAH1 MIPOL1 ANKRD11 AFF1 SMYD3 SOS2 | 1.32e-06 | 1489 | 101 | 17 | 28611215 |
| Pubmed | 1.97e-06 | 9 | 101 | 3 | 24292102 | ||
| Pubmed | Expression of glutamate receptor subunit genes during development of the mouse retina. | 1.97e-06 | 9 | 101 | 3 | 9051806 | |
| Pubmed | 5.13e-06 | 12 | 101 | 3 | 11891216 | ||
| Pubmed | GRIA1 GRIA4 PDE10A SEC22A CC2D2B IVNS1ABP SAMD9L ZNF451 SCN9A HYDIN ARL14 | 5.17e-06 | 686 | 101 | 11 | 29987050 | |
| Pubmed | Glutamatergic gene variants impact the clinical profile of efficacy and side effects of haloperidol. | 6.66e-06 | 13 | 101 | 3 | 20859245 | |
| Pubmed | 6.66e-06 | 13 | 101 | 3 | 25218043 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | OFD1 STK32C NSMCE2 IVNS1ABP LATS1 N4BP2 BRD4 ANKRD11 FIP1L1 NR3C2 CEP152 CDC25B | 7.79e-06 | 861 | 101 | 12 | 36931259 |
| Pubmed | Amyloid-β effects on synapses and memory require AMPA receptor subunit GluA3. | 8.35e-06 | 2 | 101 | 2 | 27708157 | |
| Pubmed | Synaptic plasticity through activation of GluA3-containing AMPA-receptors. | 8.35e-06 | 2 | 101 | 2 | 28762944 | |
| Pubmed | Kinetic properties of human AMPA-type glutamate receptors expressed in HEK293 cells. | 8.35e-06 | 2 | 101 | 2 | 12670305 | |
| Pubmed | Control of kinetic properties of AMPA receptor channels by nuclear RNA editing. | 8.35e-06 | 2 | 101 | 2 | 7992055 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 20579352 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 22623657 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 28103481 | ||
| Pubmed | Elimination of redundant synaptic inputs in the absence of synaptic strengthening. | 8.35e-06 | 2 | 101 | 2 | 22090494 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 18305116 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 30737285 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 31817997 | ||
| Pubmed | Distinct effects of AMPAR subunit depletion on spatial memory. | 8.35e-06 | 2 | 101 | 2 | 37876813 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 35489388 | ||
| Pubmed | Absence seizures in C3H/HeJ and knockout mice caused by mutation of the AMPA receptor subunit Gria4. | 8.35e-06 | 2 | 101 | 2 | 18316356 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 17928436 | ||
| Pubmed | Characterization of the functional role of the N-glycans in the AMPA receptor ligand-binding domain. | 8.35e-06 | 2 | 101 | 2 | 12603841 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 36919662 | ||
| Pubmed | BRD4 Inhibition Attenuates Inflammatory Pain by Ameliorating NLRP3 Inflammasome-Induced Pyroptosis. | 8.35e-06 | 2 | 101 | 2 | 35154163 | |
| Pubmed | GluA4 is indispensable for driving fast neurotransmission across a high-fidelity central synapse. | 8.35e-06 | 2 | 101 | 2 | 21690196 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 21156788 | ||
| Pubmed | 1.05e-05 | 15 | 101 | 3 | 9481670 | ||
| Pubmed | PICK1 interacts with ABP/GRIP to regulate AMPA receptor trafficking. | 1.30e-05 | 16 | 101 | 3 | 16055064 | |
| Pubmed | MIS18BP1 OFD1 MED9 HAUS3 LIG3 PBRM1 MED11 MED25 FIP1L1 CEP152 | 1.90e-05 | 645 | 101 | 10 | 25281560 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 36070750 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 17296559 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 22094384 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 28397107 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 32569783 | ||
| Pubmed | Long-term potentiation reconstituted with an artificial TARP/PSD-95 complex. | 2.50e-05 | 3 | 101 | 2 | 36223737 | |
| Pubmed | Persistent synaptic scaling independent of AMPA receptor subunit composition. | 2.50e-05 | 3 | 101 | 2 | 23864664 | |
| Pubmed | AMPA receptor anchoring at CA1 synapses is determined by N-terminal domain and TARP γ8 interactions. | 2.50e-05 | 3 | 101 | 2 | 34426577 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 22057216 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 15144856 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 18163426 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 12700243 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 19858198 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 21330445 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 17611414 | ||
| Pubmed | The Wnt receptor Ryk plays a role in mammalian planar cell polarity signaling. | 2.50e-05 | 3 | 101 | 2 | 22773843 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 15145077 | ||
| Pubmed | Synaptic transmission and plasticity require AMPA receptor anchoring via its N-terminal domain. | 2.50e-05 | 3 | 101 | 2 | 28290985 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 26585043 | ||
| Pubmed | Glutamatergic plasticity by synaptic delivery of GluR-B(long)-containing AMPA receptors. | 2.50e-05 | 3 | 101 | 2 | 14687553 | |
| Pubmed | Synaptic homeostasis requires the membrane-proximal carboxy tail of GluA2. | 2.50e-05 | 3 | 101 | 2 | 29180434 | |
| Pubmed | Case-control association study of GRIA1, GRIA2 and GRIA4 polymorphisms in bipolar disorder. | 2.50e-05 | 3 | 101 | 2 | 22122651 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 21854770 | ||
| Pubmed | Subunit composition of synaptic AMPA receptors revealed by a single-cell genetic approach. | 2.50e-05 | 3 | 101 | 2 | 19409270 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 21135237 | ||
| Pubmed | Subunit-specific role for the amino-terminal domain of AMPA receptors in synaptic targeting. | 2.50e-05 | 3 | 101 | 2 | 28630296 | |
| Pubmed | LTP requires a reserve pool of glutamate receptors independent of subunit type. | 2.50e-05 | 3 | 101 | 2 | 23235828 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | TLK2 UACA CENPE U2SURP DNAJB4 HAUS3 PROSER1 NSMCE2 PBRM1 ZNF451 ASPM CEP152 CDC25B | 3.05e-05 | 1155 | 101 | 13 | 20360068 |
| Pubmed | GTPBP4 MIS18BP1 DNAJB4 LIG3 PBRM1 ZNF451 BRD4 MED11 MED25 FIP1L1 SMS MBD4 | 3.89e-05 | 1014 | 101 | 12 | 32416067 | |
| Pubmed | 4.04e-05 | 23 | 101 | 3 | 8464923 | ||
| Pubmed | Glutamate can act as a signaling molecule in mouse preimplantation embryos†. | 4.60e-05 | 24 | 101 | 3 | 35746896 | |
| Pubmed | 4.60e-05 | 24 | 101 | 3 | 22632720 | ||
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 20083600 | ||
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 28608780 | ||
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 26932439 | ||
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 31231192 | ||
| Pubmed | A Minor Subset of Super Elongation Complexes Plays a Predominant Role in Reversing HIV-1 Latency. | 4.99e-05 | 4 | 101 | 2 | 26830226 | |
| Pubmed | Mea6 controls VLDL transport through the coordinated regulation of COPII assembly. | 4.99e-05 | 4 | 101 | 2 | 27311593 | |
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 31244610 | ||
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 31992779 | ||
| Pubmed | Genetic and clinical predictors of sexual dysfunction in citalopram-treated depressed patients. | 4.99e-05 | 4 | 101 | 2 | 19295509 | |
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 29915039 | ||
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 21807889 | ||
| Pubmed | Long-term potentiation is independent of the C-tail of the GluA1 AMPA receptor subunit. | 4.99e-05 | 4 | 101 | 2 | 32831170 | |
| Interaction | CTAGE1 interactions | 1.08e-07 | 10 | 98 | 4 | int:CTAGE1 | |
| Cytoband | 7q35 | 6.90e-06 | 55 | 101 | 4 | 7q35 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q35 | 1.43e-05 | 66 | 101 | 4 | chr7q35 | |
| GeneFamily | CTAGE family | 2.72e-09 | 15 | 73 | 5 | 907 | |
| GeneFamily | Glutamate ionotropic receptor AMPA type subunits | 2.52e-07 | 4 | 73 | 3 | 1200 | |
| GeneFamily | Cyclins|Mediator complex | 3.16e-04 | 33 | 73 | 3 | 1061 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 3.33e-04 | 7 | 73 | 2 | 1299 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 3.45e-04 | 34 | 73 | 3 | 487 | |
| GeneFamily | PRAME family | 4.19e-03 | 24 | 73 | 2 | 686 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | TLK2 MIS18BP1 UACA CENPE MYO6 HAUS3 PROSER1 SNRNP48 ZFYVE9 ASPM ANKRD11 | 1.08e-05 | 469 | 98 | 11 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.69e-05 | 259 | 98 | 8 | gudmap_developingGonad_e12.5_epididymis_k3_1000 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-07 | 184 | 101 | 7 | 16aa8e88bdd51b1d132d5cf33c29963b384a8bae | |
| ToppCell | PND01-03-samps-Myeloid-Macrophage-macrophage-B|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.31e-06 | 152 | 101 | 6 | 5ce8920aedd39a4daf7082153b5e213707c14227 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.72e-06 | 182 | 101 | 6 | 3dec003bad0f3716cf8163861a9d4302a7d6df8c | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.84e-06 | 183 | 101 | 6 | 52af3c943116073c8ddd207b664342960b88929b | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.08e-06 | 185 | 101 | 6 | afbb88325e4a81c15ac1d0a004e3e1f4ba2ee87b | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.08e-06 | 185 | 101 | 6 | b4af9ae4c358b48357cb135b740266e1652d886a | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.34e-06 | 187 | 101 | 6 | f3397dbc23b6c2f24e2c1ba887d8f9aef3ee01a1 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.76e-06 | 190 | 101 | 6 | 474cbbab8f3b0a6881fa6c92edb78e43999f9ab0 | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-Proliferating_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.91e-06 | 191 | 101 | 6 | 239300ff76f2c855b2b04d3002461158be90a01b | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Macrophage_alveolar-Macro_alv_dividing|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.52e-06 | 195 | 101 | 6 | c96755d2eb98112b703b5dbee9c88730ace7dcbf | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 5.86e-06 | 197 | 101 | 6 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.39e-06 | 200 | 101 | 6 | 89821a264e872ed53e08e9d3609d5cc5c314503e | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.76e-05 | 155 | 101 | 5 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.76e-05 | 155 | 101 | 5 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | NS-moderate-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.93e-05 | 157 | 101 | 5 | 410c9d74a2085179cfb39853cb6d330fa98c9c1b | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.62e-05 | 164 | 101 | 5 | ae09e5aabd1347b865474255e7411c04f63efb3b | |
| ToppCell | droplet-Skin-nan-18m-Epithelial-stem_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.72e-05 | 165 | 101 | 5 | 96f0d8bc9b13e23f757e6bb98cd7dc061a8a9564 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.83e-05 | 166 | 101 | 5 | bb8135119dc37fdbba476599a56d368f422688dc | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.17e-05 | 169 | 101 | 5 | a1efc20e34a81ae32f8d278a5486811ade03ef24 | |
| ToppCell | TCGA-Brain|World / Sample_Type by Project: Shred V9 | 4.29e-05 | 170 | 101 | 5 | f78e360a6a44d599ec0d207cba4704e50aa314f8 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.79e-05 | 174 | 101 | 5 | 72df66319f6efbd88ecf439013d97409fbf3cb52 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.79e-05 | 174 | 101 | 5 | c6087fd0e036ec7f40f0f8f17d1f6ce13ddb5235 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.34e-05 | 178 | 101 | 5 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.63e-05 | 180 | 101 | 5 | 544fb373a3346186ec60afe2cfcf141bb04a1eed | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.63e-05 | 180 | 101 | 5 | 43fd5c498a87bb078d101298b472656f3294686a | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.63e-05 | 180 | 101 | 5 | 30cf3c7ee29694eaccb89bf8053a82037d5c9f1d | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.93e-05 | 182 | 101 | 5 | 904804813849b7f7f716ba1554d33b07bc0a701e | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.93e-05 | 182 | 101 | 5 | 5d8b7fe18286e27f0f50c5d2d9be56850e2cb8f4 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.09e-05 | 183 | 101 | 5 | 42dc31d587fbb9724b2f0be5ee8ed77233f67b86 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.09e-05 | 183 | 101 | 5 | e91f00b75d43ee6293fdd4a129b789cd95f8d11a | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.25e-05 | 184 | 101 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.25e-05 | 184 | 101 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.25e-05 | 184 | 101 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.41e-05 | 185 | 101 | 5 | 57c1eb50a4456d20953e48d5dc3b0ea3d0d81b6d | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.41e-05 | 185 | 101 | 5 | 775b72319ef6acffd2c9a74293b9c1bccea33f42 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 6.41e-05 | 185 | 101 | 5 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.91e-05 | 188 | 101 | 5 | 73f6ec915934154f435a376cb274b058ff7c5f35 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.09e-05 | 189 | 101 | 5 | 287e59104687fe1665232c52993889f0f2c97f17 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neuron_precursor-cycling_neuroblast|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.09e-05 | 189 | 101 | 5 | 815afad947ed77a8b03724bf78014799fed34f54 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.09e-05 | 189 | 101 | 5 | 6d24414ac6bd4f03f7a5ad3a6eba51d549a7b112 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-05 | 190 | 101 | 5 | 4288189e3a499c395896c950598810b02f401685 | |
| ToppCell | RV-08._Macrophage|World / Chamber and Cluster_Paper | 7.64e-05 | 192 | 101 | 5 | a1b5dc5beb97a23729b97b54fb4574d10d8fbfb3 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.64e-05 | 192 | 101 | 5 | 27723f4e320e49d4a3daafa2d8d3946ff79fab64 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.64e-05 | 192 | 101 | 5 | 0a54c79dcfdeb99e3b512d42b22359618cfd17e9 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.64e-05 | 192 | 101 | 5 | c618ede75dce3988c87a5b8f98d8e94e1dd66efd | |
| ToppCell | COVID-19-lung-Lymphatic_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.64e-05 | 192 | 101 | 5 | cbe57cda44232b183821ac633b60a2668265e616 | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 7.64e-05 | 192 | 101 | 5 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 7.82e-05 | 193 | 101 | 5 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.82e-05 | 193 | 101 | 5 | a3636c35ed25aabe2f1aba016c9fe125327bbfaf | |
| ToppCell | moderate-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.02e-05 | 194 | 101 | 5 | dff3fb10372053951d41e0ccd41aac3ece6009bd | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.21e-05 | 195 | 101 | 5 | c1435e61e4f0cf457f26ae436936048932ceb0db | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Proliferating-Cycling_Progenitors|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 8.41e-05 | 196 | 101 | 5 | 5905f0e3061a6b98b7a33d64c782c3dda2cd51ef | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-sinusoidal_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.62e-05 | 197 | 101 | 5 | 4e58bbf3ecb30b4c8199adcc04d2eb134d90de56 | |
| ToppCell | myeloid-pro-pDC|World / Lineage and Cell class | 8.62e-05 | 197 | 101 | 5 | 8918ee006b16f6b86ed33ce1dd5c0f01f51f88f5 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Proliferating-cycling_dorsal_progenitors|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 8.83e-05 | 198 | 101 | 5 | 5f0964c3aa7e1dc52cbb46e754078920b65bcb88 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Proliferating|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 8.83e-05 | 198 | 101 | 5 | 629d674a9c9108c1acb3f7af57bbdbf34bb0528e | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Proliferating-cycling_dorsal_progenitors|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 8.83e-05 | 198 | 101 | 5 | dada1c19a261c8e1090957cd7e37f2a43a9fe14f | |
| ToppCell | 15-Airway-Mesenchymal-Mesenchyme_RSPO2+|Airway / Age, Tissue, Lineage and Cell class | 9.04e-05 | 199 | 101 | 5 | 5c8b847b794b3e88722f5b841f2539a27251106c | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div1-28|World / Primary Cells by Cluster | 9.04e-05 | 199 | 101 | 5 | 787688b68ae5d8768c0a24673ae07ab07616764a | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Proliferating-Cycling_Progenitors|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 9.04e-05 | 199 | 101 | 5 | a99516a5760f49a69b0fe45a9b2316e393252966 | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div1|World / Primary Cells by Cluster | 9.04e-05 | 199 | 101 | 5 | 72823f26ecabcae1b514b7629cfce010c97b929a | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Proliferating-cycling_dorsal_progenitors|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 9.04e-05 | 199 | 101 | 5 | ca17e8c0f5bc2c41ce28351a7418d934404e563b | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Proliferating-cycling_ventral_progenitors|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 9.04e-05 | 199 | 101 | 5 | 446cd7d960812519fe2b8e434578ef0b668c75ce | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Proliferating|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 9.04e-05 | 199 | 101 | 5 | d8f904f531bfe091b7d8caaa147ea4a03d627995 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Stem_cells-Neuroepithelial_cell|10w / Sample Type, Dataset, Time_group, and Cell type. | 9.25e-05 | 200 | 101 | 5 | 8f8b8c225cdc79baf16fe04be89bdb65e404a055 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Stem_cells|10w / Sample Type, Dataset, Time_group, and Cell type. | 9.25e-05 | 200 | 101 | 5 | a1f48eca9efb4f3ec3c9ace20f8c9257dd72c4ed | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Stem_cells-Neuroepithelial_cell|3m / Sample Type, Dataset, Time_group, and Cell type. | 9.25e-05 | 200 | 101 | 5 | 2938a029fa0478be561574ace91f95c4a528b2d4 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells-Neuroepithelial_cell|2m / Sample Type, Dataset, Time_group, and Cell type. | 9.25e-05 | 200 | 101 | 5 | 0d9b8d51a7630e70e60c76c763ff82df4c559152 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.25e-05 | 200 | 101 | 5 | bcd1cc96197929d6011903803b6f4ccdcf52b4ce | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 9.25e-05 | 200 | 101 | 5 | edb64556b3fefe3144f73b6efe23b9ffd34091d2 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells|2m / Sample Type, Dataset, Time_group, and Cell type. | 9.25e-05 | 200 | 101 | 5 | 0675f580ccef705875854247bbfd4ee2bcf126a1 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Proliferating-cycling_ventral_progenitors|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 9.25e-05 | 200 | 101 | 5 | 9359faa749f41aaef70b4874f20b4eed2dc12cc2 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Stem_cells|3m / Sample Type, Dataset, Time_group, and Cell type. | 9.25e-05 | 200 | 101 | 5 | cfe017b4a4d604a553d0a3df9659687f38e9a7af | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.25e-05 | 200 | 101 | 5 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Stem_cells-Neuroepithelial_cell|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 9.25e-05 | 200 | 101 | 5 | 203b9a5de4430713da01b3331e69381db449a3a0 | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2|World / Primary Cells by Cluster | 9.25e-05 | 200 | 101 | 5 | 4923d7a4f00853c4d76fc1cc0fa82d522a2302e7 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Stem_cells|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 9.25e-05 | 200 | 101 | 5 | a854e19703dc920e48304541e2b06ed013292f3e | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Proliferating|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 9.25e-05 | 200 | 101 | 5 | cea58274efbe7f9e3c3ef9fbb768ebfb917e21d9 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW16-Stem_cells|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 9.25e-05 | 200 | 101 | 5 | b71138729d2a81cc2f30e3bc15853516a525a17f | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Stem_cells|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 9.25e-05 | 200 | 101 | 5 | 008f137920cc3b599376706803c111d1d0ec17ef | |
| ToppCell | Non-neuronal-Dividing-IPC|World / Primary Cells by Cluster | 9.25e-05 | 200 | 101 | 5 | 971533181daa1bfac1f1b8c507d2013f891f9078 | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2-5|World / Primary Cells by Cluster | 9.25e-05 | 200 | 101 | 5 | dc1c1506823eaa105f1532c6b5d4efa14e788314 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Activated_Alv_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 9.25e-05 | 200 | 101 | 5 | be55cef682ba87250dad97689332c8820b3a7420 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW16-Stem_cells-Stem_cells|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 9.25e-05 | 200 | 101 | 5 | 8f3067b52865a0f5488e4df0d5a4fea80135cef5 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Stem_cells-Neuroepithelial_cell|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 9.25e-05 | 200 | 101 | 5 | 0e119c2742f2be19fde8890d1227bf277ead976f | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Proliferating|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 9.25e-05 | 200 | 101 | 5 | 8f9e76048ae6f45218a09a95a2c4b31e8a8937b2 | |
| ToppCell | ILEUM-non-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.53e-04 | 135 | 101 | 4 | b7a792a7c0c22d8b703509f134115f0e394d7de0 | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast-matrix_-_mature_3|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 2.67e-04 | 137 | 101 | 4 | 9bfdbc102cdd861996b3c4eac35b606be8af97eb | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 2.75e-04 | 138 | 101 | 4 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | Healthy-CD4+_T_activated|World / disease group, cell group and cell class | 2.90e-04 | 140 | 101 | 4 | 407691970ec72a3afb45e431cf48814546b8acff | |
| ToppCell | COVID-19_Mild-Neu_2|World / 5 Neutrophil clusters in COVID-19 patients | 2.90e-04 | 140 | 101 | 4 | b1429028c52f84127b894b93b55961badcd5246f | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-Neu_2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.15e-04 | 143 | 101 | 4 | 9836a040a2ebcf6f05431e658a7b8fd566621452 | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-Neu_2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.15e-04 | 143 | 101 | 4 | 4622c221b5d2d4cd4f37e4f81662e073924e1507 | |
| ToppCell | Healthy-CD4+_T_activated|Healthy / disease group, cell group and cell class | 3.32e-04 | 145 | 101 | 4 | 45e8089fdf7d6f69b383816d8945e39fba24c873 | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.58e-04 | 148 | 101 | 4 | d61123f0c811287843d066b932b4a9ff09c07c5b | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.58e-04 | 148 | 101 | 4 | c8e93b87212f55774223caa385859c566fa1981f | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells-Ciliated|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.16e-04 | 154 | 101 | 4 | 9ca71d440c4f87781e6525b8141e7d8d470b6a8e | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.16e-04 | 154 | 101 | 4 | 58072ce422d09f2de602580325eaac6c4ec6c136 | |
| ToppCell | facs-Trachea-nan-3m-Myeloid-lymphocyte_of_B_lineage|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.48e-04 | 157 | 101 | 4 | 0fecc14959c4c9efc19d5c06475a890e0a30f148 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_D_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.48e-04 | 157 | 101 | 4 | 370f44047ef438b8f1124c2c2761c150c0d8c57f | |
| Drug | isothiazol-3-one | 3.84e-08 | 9 | 97 | 4 | CID000096917 | |
| Drug | 3-pyridazinol 1-oxide | 2.99e-07 | 4 | 97 | 3 | CID000574311 | |
| Drug | AC1L1YEG | 7.45e-07 | 5 | 97 | 3 | CID000063114 | |
| Drug | Chicago acid | 7.45e-07 | 5 | 97 | 3 | CID000065740 | |
| Drug | CHEBI:570577 | 7.45e-07 | 5 | 97 | 3 | CID011334126 | |
| Drug | 1-BCP | 7.45e-07 | 5 | 97 | 3 | CID000001370 | |
| Drug | irampanel | 7.45e-07 | 5 | 97 | 3 | CID003038472 | |
| Drug | beta-N-oxalylaminoalanine | 7.45e-07 | 5 | 97 | 3 | CID000107978 | |
| Drug | LY395153 | 7.45e-07 | 5 | 97 | 3 | CID000656707 | |
| Drug | 5-h PCA | 7.45e-07 | 5 | 97 | 3 | CID000129091 | |
| Drug | 2cmo | 1.49e-06 | 6 | 97 | 3 | CID006914597 | |
| Drug | YM928 | 1.49e-06 | 6 | 97 | 3 | CID006918393 | |
| Drug | M100907 | 2.54e-06 | 51 | 97 | 5 | CID000060858 | |
| Drug | thio-ATPA | 2.59e-06 | 7 | 97 | 3 | CID005289517 | |
| Drug | 4,6-dichloroindole-2-carboxylic acid | 2.59e-06 | 7 | 97 | 3 | CID000127988 | |
| Drug | 2,3-PDCA | 4.13e-06 | 8 | 97 | 3 | CID000127037 | |
| Drug | homoibotenic acid | 4.13e-06 | 8 | 97 | 3 | CID000194385 | |
| Drug | 1-hydroxypyrazole | 4.13e-06 | 8 | 97 | 3 | CID003016733 | |
| Drug | 1-hydroxyimidazole | 4.13e-06 | 8 | 97 | 3 | CID003614351 | |
| Drug | Ly294486 | 6.18e-06 | 9 | 97 | 3 | CID005311255 | |
| Drug | 1m5b | 6.18e-06 | 9 | 97 | 3 | CID000447081 | |
| Drug | Benzoates | 8.80e-06 | 10 | 97 | 3 | ctd:D001565 | |
| Drug | 0-ol | 1.21e-05 | 11 | 97 | 3 | CID000069892 | |
| Drug | J-ST | 1.21e-05 | 11 | 97 | 3 | CID005288655 | |
| Drug | sym 2206 | 1.21e-05 | 11 | 97 | 3 | CID005039877 | |
| Drug | YM872 | 1.21e-05 | 11 | 97 | 3 | CID000148200 | |
| Drug | 5-Acetamido-5,6-Dihydro-4-Hydroxy-6-Isobutoxy-4h-Pyran-2-Carboxylic Acid | 1.51e-05 | 73 | 97 | 5 | CID011963505 | |
| Drug | C-X6 | 1.60e-05 | 12 | 97 | 3 | CID005288002 | |
| Drug | Atpa | 1.60e-05 | 12 | 97 | 3 | CID000002252 | |
| Drug | 1NaPP1 | 1.60e-05 | 12 | 97 | 3 | CID000004877 | |
| Drug | 5-fluorowillardiine | 1.80e-05 | 2 | 97 | 2 | ctd:C095178 | |
| Drug | KSCN | 1.84e-05 | 37 | 97 | 4 | CID000516872 | |
| Drug | Naspm | 2.08e-05 | 13 | 97 | 3 | CID000129695 | |
| Drug | Ribostamycin sulfate salt [53797-35-6]; Down 200; 7.2uM; MCF7; HT_HG-U133A | 2.17e-05 | 197 | 97 | 7 | 3444_DN | |
| Drug | Vidarabine [5536-17-4]; Down 200; 15uM; MCF7; HT_HG-U133A | 2.32e-05 | 199 | 97 | 7 | 3445_DN | |
| Drug | quinoxaline-2,3-dione | 2.64e-05 | 14 | 97 | 3 | CID011469229 | |
| Drug | thiokynurenic acid | 3.29e-05 | 15 | 97 | 3 | CID003035667 | |
| Drug | Joro spider toxin | 3.36e-05 | 43 | 97 | 4 | CID000119582 | |
| Drug | LY233536 | 4.03e-05 | 16 | 97 | 3 | CID000126239 | |
| Drug | decahydroisoquinoline | 4.03e-05 | 16 | 97 | 3 | CID000097812 | |
| Drug | 7-Cl-Thio-Kyna | 4.88e-05 | 17 | 97 | 3 | CID003035668 | |
| Drug | PPNDS | 4.88e-05 | 17 | 97 | 3 | CID005961627 | |
| Drug | methylenecyclopropylglycine | 5.66e-05 | 49 | 97 | 4 | CID000441452 | |
| Drug | MNQX | 5.84e-05 | 18 | 97 | 3 | CID000130818 | |
| Drug | LY382884 | 6.91e-05 | 19 | 97 | 3 | CID000656723 | |
| Drug | lacosamide | 7.16e-05 | 52 | 97 | 4 | CID000219078 | |
| Drug | IDRA 21 | 8.11e-05 | 20 | 97 | 3 | CID000003688 | |
| Drug | AC1L1B62 | 9.43e-05 | 21 | 97 | 3 | CID000001299 | |
| Drug | 3-isoxazolol | 1.07e-04 | 4 | 97 | 2 | CID009964065 | |
| Drug | sunifiram | 1.07e-04 | 4 | 97 | 2 | CID004223812 | |
| Drug | 4-(chloromethyl)-3-methoxy-5-methylisoxazole | 1.07e-04 | 4 | 97 | 2 | CID011105661 | |
| Drug | NS 102 | 1.09e-04 | 22 | 97 | 3 | CID005282252 | |
| Drug | Fe-mo-s Cluster | 1.09e-04 | 22 | 97 | 3 | CID000445682 | |
| Drug | CX516 | 1.09e-04 | 22 | 97 | 3 | CID000148184 | |
| Drug | troglitazone; Up 200; 10uM; PC3; HT_HG-U133A | 1.19e-04 | 179 | 97 | 6 | 4456_UP | |
| Drug | CGP 39653 | 1.42e-04 | 24 | 97 | 3 | CID006437837 | |
| Drug | pD 8 | 1.42e-04 | 24 | 97 | 3 | CID000656948 | |
| Drug | Ns102 | 1.61e-04 | 25 | 97 | 3 | CID005311098 | |
| Drug | AC1NBNXJ | 1.78e-04 | 5 | 97 | 2 | CID004470983 | |
| Drug | Astemizole [68844-77-9]; Down 200; 8.8uM; PC3; HT_HG-U133A | 1.79e-04 | 193 | 97 | 6 | 2049_DN | |
| Drug | 17-hydroxyprogesterone | 1.84e-04 | 123 | 97 | 5 | CID000006238 | |
| Drug | Thiamphenicol [15318-45-3]; Up 200; 11.2uM; PC3; HT_HG-U133A | 2.00e-04 | 197 | 97 | 6 | 1826_UP | |
| Drug | Propantheline bromide [50-34-0]; Down 200; 9uM; HL60; HT_HG-U133A | 2.05e-04 | 198 | 97 | 6 | 3013_DN | |
| Drug | Methazolamide [554-57-4]; Up 200; 17uM; PC3; HT_HG-U133A | 2.11e-04 | 199 | 97 | 6 | 5794_UP | |
| Drug | Protoveratrine A [143-57-7]; Up 200; 5uM; PC3; HT_HG-U133A | 2.11e-04 | 199 | 97 | 6 | 6618_UP | |
| Drug | Acebutolol hydrochloride [34381-68-5]; Up 200; 10.8uM; PC3; HT_HG-U133A | 2.11e-04 | 199 | 97 | 6 | 6631_UP | |
| Drug | Isopropamide iodide [71-81-8]; Down 200; 8.4uM; PC3; HT_HG-U133A | 2.11e-04 | 199 | 97 | 6 | 7133_DN | |
| Drug | Folic acid [59-30-3]; Up 200; 9uM; PC3; HT_HG-U133A | 2.11e-04 | 199 | 97 | 6 | 5844_UP | |
| Drug | PNU-0230031 [267429-39-0]; Up 200; 1uM; PC3; HT_HG-U133A | 2.17e-04 | 200 | 97 | 6 | 3735_UP | |
| Drug | AC1NUW3V | 2.53e-04 | 29 | 97 | 3 | CID005462126 | |
| Drug | rufinamide | 2.53e-04 | 29 | 97 | 3 | CID000129228 | |
| Drug | benzamil | 2.55e-04 | 72 | 97 | 4 | CID000108107 | |
| Drug | AdoDatad | 2.66e-04 | 6 | 97 | 2 | CID003081160 | |
| Drug | M2 t | 2.66e-04 | 6 | 97 | 2 | CID000167321 | |
| Drug | AC1L9FMM | 2.69e-04 | 73 | 97 | 4 | CID000444055 | |
| Drug | LY293558 | 2.80e-04 | 30 | 97 | 3 | CID000127894 | |
| Drug | AC1L32TU | 2.80e-04 | 30 | 97 | 3 | CID000107831 | |
| Drug | 4-methylglutamic acid | 3.09e-04 | 31 | 97 | 3 | CID000005365 | |
| Drug | KW-6002 | 3.40e-04 | 32 | 97 | 3 | CID005311037 | |
| Drug | willardine | 3.40e-04 | 32 | 97 | 3 | CID000005123 | |
| Drug | alpha-methyl-4-carboxyphenylglycine | 3.40e-04 | 32 | 97 | 3 | CID000001222 | |
| Disease | Autosomal recessive primary microcephaly | 1.30e-05 | 15 | 92 | 3 | cv:C3711387 | |
| Disease | central nervous system disease (implicated_via_orthology) | 1.59e-05 | 16 | 92 | 3 | DOID:331 (implicated_via_orthology) | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 1.93e-05 | 17 | 92 | 3 | DOID:0060307 (is_implicated_in) | |
| Disease | Warsaw breakage syndrome (implicated_via_orthology) | 2.88e-05 | 3 | 92 | 2 | DOID:0060535 (implicated_via_orthology) | |
| Disease | Hypoactive Sexual Desire Disorder | 1.43e-04 | 6 | 92 | 2 | C0020594 | |
| Disease | Sexual Arousal Disorder | 1.43e-04 | 6 | 92 | 2 | C0036902 | |
| Disease | Frigidity | 1.43e-04 | 6 | 92 | 2 | C0016722 | |
| Disease | Psychosexual Disorders | 1.43e-04 | 6 | 92 | 2 | C0033953 | |
| Disease | Orgasmic Disorder | 1.43e-04 | 6 | 92 | 2 | C0029261 | |
| Disease | Kartagener Syndrome | 1.79e-04 | 35 | 92 | 3 | C0022521 | |
| Disease | Polynesian Bronchiectasis | 1.79e-04 | 35 | 92 | 3 | C4317124 | |
| Disease | Ciliary Dyskinesia, Primary, 1, With Or Without Situs Inversus | 1.79e-04 | 35 | 92 | 3 | C4551906 | |
| Disease | Primary Ciliary Dyskinesia | 4.31e-04 | 47 | 92 | 3 | C4551720 | |
| Disease | serum selenium measurement | 6.14e-04 | 53 | 92 | 3 | EFO_0005266 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 1.12e-03 | 145 | 92 | 4 | DOID:1289 (implicated_via_orthology) | |
| Disease | diastolic blood pressure, systolic blood pressure | 1.18e-03 | 670 | 92 | 8 | EFO_0006335, EFO_0006336 | |
| Disease | Seckel syndrome | 2.13e-03 | 22 | 92 | 2 | C0265202 | |
| Disease | Primary microcephaly | 2.13e-03 | 22 | 92 | 2 | C0431350 | |
| Disease | Autosomal Recessive Primary Microcephaly | 2.13e-03 | 22 | 92 | 2 | C3711387 | |
| Disease | bipolar disorder | 2.21e-03 | 577 | 92 | 7 | MONDO_0004985 | |
| Disease | platelet reactivity measurement, response to clopidogrel | 2.33e-03 | 23 | 92 | 2 | EFO_0004985, GO_1903493 | |
| Disease | hypertension | 2.78e-03 | 307 | 92 | 5 | EFO_0000537 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QARKMCNYDKILATK | 1806 | Q9NR48 | |
| KIKCDMLRYIQESKE | 1276 | O94986 | |
| DKYDRMKTCLLMRQQ | 2596 | Q6UB99 | |
| AKIICKTFKMSEERR | 191 | Q8IX94 | |
| AKIICKTFKMSEERR | 191 | Q86UF2 | |
| AKIICKTFKMSEERR | 191 | P0CG41 | |
| AKIICKTFKMSEERR | 191 | A4FU28 | |
| AKIICKTFKMSEERR | 191 | A4D2H0 | |
| RYKKPMKVDSICNLD | 151 | A5X5Y0 | |
| KCKPMSYEEKRQLSL | 606 | O60885 | |
| NCNREYDLLMKEKSR | 161 | Q6TFL3 | |
| RMCTVIKRQKQSLEY | 136 | Q9BZE4 | |
| KRLIEMTAEYACTRK | 316 | Q9H845 | |
| ITRMFKVKKLCSDRN | 136 | Q8N4G2 | |
| ELQCLALRKDSKMYK | 326 | Q9H257 | |
| EIYKKTCNKMENRLL | 206 | Q6DHV5 | |
| KREEYMQMRESCIKL | 1721 | Q8IZT6 | |
| RYKRSKLERQMNCDV | 296 | O60312 | |
| NCREEKKSSTKLRMD | 81 | Q7Z5L2 | |
| KRMIKRACEQLSSRY | 306 | Q6ZSC3 | |
| LRAEMCQKLKFFKDT | 211 | O75665 | |
| LCESRYNESDKQMKK | 1256 | Q86U86 | |
| RTNYIKELRKMVTKC | 896 | P08235 | |
| KSRKVIEQRCMRYNL | 656 | Q6P0N0 | |
| ILKADMLKCVRREYK | 216 | Q8N7X4 | |
| KLKMDRVKQVCGDYL | 111 | Q9Y6Y0 | |
| DRIYKTKECKMRITA | 246 | Q8TD10 | |
| CQKESNYIRLKRAKM | 686 | O95835 | |
| CRMQKYEDIKSKEEQ | 246 | P51674 | |
| KKCYQMIDRRLRKNL | 251 | Q86WG3 | |
| KKSYDNEKRLMAKCR | 51 | Q5T655 | |
| RMAKRVRKDYKYVQC | 351 | Q9P1W3 | |
| FCYKSRAESKRMKLT | 846 | P42263 | |
| FCYKSRAEAKRMKLT | 836 | P48058 | |
| EKLCRFIMSVKKNYR | 496 | Q9Y233 | |
| ISKERLSYKEAMGRC | 1986 | Q92817 | |
| QKIKKANECASRLMY | 496 | Q8NA70 | |
| KAYCEKQKRIRMGLE | 186 | Q6UN15 | |
| RMIESRQKRKKKAYC | 196 | Q96MF7 | |
| EKDLVMYSKCQRLFR | 306 | P30305 | |
| CEVRVLMLLYSSKKK | 506 | Q71SY5 | |
| VYRKCDKIEARKMER | 1001 | Q9UMN6 | |
| KCMFEKLERARATTK | 141 | P49916 | |
| RTKNELLQKYKSLCM | 126 | Q9NWA0 | |
| MSEKKRCKRILEQAF | 111 | Q86XN7 | |
| KKAKLLCMQRQDEYE | 326 | Q52LW3 | |
| MQAKYRECITKKEEL | 3091 | Q9P2D7 | |
| IYSGCTKRMKISRKR | 171 | Q9UDY4 | |
| CVRKSYNRKLQAMKA | 1176 | Q9BYE9 | |
| RKNTDKEYNKCEMLD | 1516 | Q4G0P3 | |
| TICRLKLEKMYSKTN | 6 | Q30KQ8 | |
| QRCRMYGAETEKLQK | 396 | P54257 | |
| KVQRYCEKSMISRKL | 496 | A8MPP1 | |
| LFKVQRYCEKSMISR | 511 | Q92771 | |
| SKRNKDVDMLCDTLY | 501 | Q68CZ6 | |
| ERQKEKASMLCFKRR | 26 | P24588 | |
| RILKMQYCTNISKKA | 661 | Q8NEE6 | |
| LSKRGIKSRYKDCSM | 146 | O95243 | |
| LMTADRKDYEKICLK | 171 | Q86VF2 | |
| IEFCYKSRSESKRMK | 826 | P42261 | |
| QECRKYFKMLSRKLA | 31 | Q96IW7 | |
| LNFKRRKMCYKKLEE | 186 | P34925 | |
| KCSRIKELLKRYSEM | 2096 | Q02224 | |
| SRKDCQMALKRVDYA | 86 | Q9P086 | |
| KEKETMDNARAFCKR | 816 | P22897 | |
| LEYLSRISICKMKKD | 121 | Q96P20 | |
| YVKVSLMCDGRRLKK | 391 | Q86SS6 | |
| KYMRKTCGDVLDNLK | 231 | P52788 | |
| CKDMTVKYDSRLRER | 76 | Q9NQ88 | |
| YRLKEKFVMRKIQIC | 486 | Q07890 | |
| CYQMIDRRLRKNLKS | 2981 | Q8WUY3 | |
| KYEECKDLLKSMLRN | 601 | Q5TAG4 | |
| TKRCNLREKISKYMD | 56 | Q8WV92 | |
| CYLKEMKNLRKLVFS | 226 | Q5SWL7 | |
| MLSKKVSRCFRKYTE | 1291 | Q8IVG5 | |
| KKRRCSSYLLSEDML | 666 | Q15858 | |
| CYLKEMKNLRKLVFS | 226 | O95521 | |
| KEKLMRCSQCRVAKY | 56 | Q9H7B4 | |
| KVCIVQKRDTEKMYA | 106 | Q86UX6 | |
| SKYSEMSEEKRAKLR | 831 | O15042 | |
| LEKYKERLNRCVTMS | 256 | Q86UE8 | |
| AMFRCKKDIAIKYSR | 1061 | P51825 | |
| TKMEYKLSFIKRCND | 931 | Q8WXI2 | |
| KVNRKEDYSRCLQIM | 731 | Q9Y4E5 | |
| DAKKCRKVYGMERRD | 356 | Q9NR83 | |
| AKKSLKRDMDRASYV | 141 | Q3SY52 | |
| NLDIKYKERSTCMKE | 581 | Q8IV35 | |
| CMYRTEKTRELVLKG | 501 | Q6ZT07 | |
| NRIKDSCVKADKMTR | 221 | Q9Y5X3 | |
| LKEELKSMQRCYEKE | 1131 | Q9BZF9 | |
| ERKYSRKKTEYMNVC | 156 | Q5TYW1 | |
| RKKTEYMNVCEKLQL | 161 | Q5TYW1 | |
| RNSYKKNICVDMLRD | 61 | Q8NA56 | |
| KRLDGCVYAIKRSMK | 231 | P0C1S8 | |
| ASCRLRKMGYTKEEE | 76 | Q6IEG0 | |
| IKERMLYSSCKSRLL | 266 | Q6IBS0 | |
| KCKLLYMDRKEARVC | 736 | O95405 | |
| KKRQLMTSCDESKRF | 531 | Q5FWF4 | |
| TYIRSSLDICRKMEK | 116 | Q8NAP8 | |
| YKAMKRRSKDTCIVI | 86 | O94832 | |
| KYRAEACIKMQKTIR | 811 | Q9UM54 | |
| QKRMECYSKAKEAYR | 1631 | Q86UW6 |